{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T13:59:39Z","timestamp":1708783179870},"reference-count":19,"publisher":"Japanese Society of Internal Medicine","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2015]]},"DOI":"10.2169\/internalmedicine.54.4762","type":"journal-article","created":{"date-parts":[[2015,9,30]],"date-time":"2015-09-30T22:04:29Z","timestamp":1443650669000},"page":"2507-2511","source":"Crossref","is-referenced-by-count":4,"title":["Refractory Dermatomyositis Complicated with Myelodysplastic Syndrome"],"prefix":"10.2169","volume":"54","author":[{"given":"Takashi","family":"Nakanishi","sequence":"first","affiliation":[{"name":"Division of Hematology and Rheumatology, Department of Internal Medicine, National Defense Medical College, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Horikoshi","sequence":"additional","affiliation":[{"name":"Division of Hematology and Rheumatology, Department of Internal Medicine, National Defense Medical College, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyoshi","family":"Kusanagi","sequence":"additional","affiliation":[{"name":"Division of Hematology and Rheumatology, Department of Internal Medicine, National Defense Medical College, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Yamamura","sequence":"additional","affiliation":[{"name":"Division of Hematology and Rheumatology, Department of Internal Medicine, National Defense Medical College, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiko","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Division of Hematology and Rheumatology, Department of Internal Medicine, National Defense Medical College, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihiko","family":"Kimura","sequence":"additional","affiliation":[{"name":"Division of Hematology and Rheumatology, Department of Internal Medicine, National Defense Medical College, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Itoh","sequence":"additional","affiliation":[{"name":"Division of Hematology and Rheumatology, Department of Internal Medicine, National Defense Medical College, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Zampieri S, Valente M, Adami N, et al. Polymyositis, dermatomyositis and malignancy: a further intriguing link. Autoimmun Rev 9: 449-453, 2010.","DOI":"10.1016\/j.autrev.2009.12.005"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Hill CL, Zhang Y, Sigurgeirsson B, et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 357: 96-100, 2001.","DOI":"10.1016\/S0140-6736(00)03540-6"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Anderson LA, Pfeiffer RM, Landgren O, Gadalla S, Berndt SI, Engels EA. Risks of myeloid malignancies in patients with autoimmune conditions. Br J Cancer 100: 822-828, 2009.","DOI":"10.1038\/sj.bjc.6604935"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Enright H, Jacob HS, Vercellotti G, Howe R, Belzer M, Miller W. Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy. Br J Haematol 91: 403-408, 1995.","DOI":"10.1111\/j.1365-2141.1995.tb05310.x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Marie I, Guillevin L, Menard JF, et al. Hematological malignancy associated with polymyositis and dermatomyositis. Autoimmun Rev 11: 615-620, 2012.","DOI":"10.1016\/j.autrev.2011.10.024"},{"key":"6","unstructured":"6. Asman A, Ehrenfeld M, Sadeh M, Feldman S, Samra Y. Polymyositis and myelodysplastic syndrome. J Rheumatol 18: 1272-1274, 1991."},{"key":"7","unstructured":"7. Maeda Y, Arakawa K, Araki E, et al. [Polymyositis and cutaneous vasculitis in a patient with myelodysplastic syndrome]. Rinsho Shinkeigaku (Clinical Neurology) 39: 639-642, 1999 (in Japanese)."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Tsuji G, Maekawa S, Saigo K, et al. Dermatomyositis and myelodysplastic syndrome with myelofibrosis responding to methotrexate therapy. Am J Hematol 74: 175-178, 2003.","DOI":"10.1002\/ajh.10430"},{"key":"9","unstructured":"9. Kanbayashi T, Masuyama A, Yokoe I, Tsuruta S, Haraoka H. A case of myelodysplastic syndrome associated with dermatomyositis, accompanying intractable gastrointestinal bleeding due to cytomegalovirus gastroenteritis. Rinsho Riumachi (Clinical Rheumatology and Related Research) 24: 81-86, 2012 (in Japanese)."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Giannouli S, Kanellopoulou T, Voulgarelis M. Myelodysplasia and autoimmunity. Curr Opin Rheumatol 24: 97-102, 2012.","DOI":"10.1097\/BOR.0b013e32834db4ee"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kawabata H, Sawaki T, Kawanami T, et al. Myelodysplastic syndrome complicated with inflammatory intestinal ulcers: significance of trisomy 8. Intern Med 45: 1309-1314, 2006.","DOI":"10.2169\/internalmedicine.45.1718"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Chen Z, Cao M, Plana MN, et al. Utility of anti-melanoma differentiation-associated gene 5 antibody measurement in identifying patients with dermatomyositis and a high risk for developing rapidly progressive interstitial lung disease: a review of the literature and a meta-analysis. Arthritis Care Res 65: 1316-1324, 2013.","DOI":"10.1002\/acr.21985"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Hoshino K, Muro Y, Sugiura K, Tomita Y, Nakashima R, Mimori T. Anti-MDA5 and anti-TIF1-gamma antibodies have clinical significance for patients with dermatomyositis. Rheumatology 49: 1726-1733, 2010.","DOI":"10.1093\/rheumatology\/keq153"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Azar L, Khasnis A. Paraneoplastic rheumatologic syndromes. Curr Opin Rheumatol 25: 44-49, 2013.","DOI":"10.1097\/BOR.0b013e328359e780"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Yamato K. Successful cord blood stem cell transplantation for myelodysplastic syndrome with Behçet disease. Int J Hematol 77: 82-85, 2003.","DOI":"10.1007\/BF02982607"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Tomonari A, Tojo A, Takahashi T, et al. Resolution of Behçet's disease after HLA-mismatched unrelated cord blood transplantation for myelodysplastic syndrome. Ann Hematol 83: 464-466, 2004.","DOI":"10.1007\/s00277-003-0819-6"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Nonami A, Takenaka K, Sumida C, et al. Successful treatment of myelodysplastic syndrome (MDS)-related intestinal Behçet's disease by up-front cord blood transplantation. Intern Med 46: 1753-1756, 2007.","DOI":"10.2169\/internalmedicine.46.0291"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Pilorge S, Doleris LM, Dreyfus F, Park S. The autoimmune manifestations associated with myelodysplastic syndrome respond to 5-azacytidine: a report on three cases. Br J Haematol 153: 664-665, 2011.","DOI":"10.1111\/j.1365-2141.2010.08557.x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Al Ustwani O, Francis J, Wallace PK, Ambrus J Jr, Wetzler M. Treating myelodysplastic syndrome improves an accompanying autoimmune disease along with a reduction in regulatory T-cells. Leuk Res 35: e35-e36, 2011.","DOI":"10.1016\/j.leukres.2010.12.015"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/54\/19\/54_54.4762\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T20:32:56Z","timestamp":1498249976000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/54\/19\/54_54.4762\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":19,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.54.4762","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}